Thermo Fisher Scientific Inc. has agreed to acquire PPD Inc., a provider of clinical and research services to the pharma and biotech industries, for $17.4 billion as healthcare deal making soars amid the pandemic.
To read the entire story, you must be logged in.
Please log in now or register with us.
